A detailed history of T. Rowe Price Investment Management, Inc. transactions in Grifols Sa stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,303,596 shares of GRFS stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,303,596
Previous 2,018,203 35.41%
Holding current value
$11.6 Million
Previous $13.5 Million 39.08%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.27 - $7.7 $4.48 Million - $5.5 Million
-714,607 Reduced 35.41%
1,303,596 $8.21 Million
Q1 2024

May 15, 2024

BUY
$5.47 - $11.38 $11 Million - $23 Million
2,018,203 New
2,018,203 $13.5 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.06B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.